Journal of Clinical Densitometry·30 SepCombined baseline P1NP and TRAcP5b classification predicts differential bone mineral density response to romosozumab: A retrospective cohort study of 287 postmenopausal womenTrial in 287 peopleP1NPPaper
Calcified Tissue International·26 SepEquivalent Twelve-Month Bone Mineral Density Response to Romosozumab in Patients Aged ≥ 85 Years and < 85 Years: A Multi-center Real-World Cohort Study (n = 417) from Northern JapanCohort study of 417 peopleRomosozumabPaper
Journal of Clinical Medicine·27 AugDevelopment of a Simple Formula for Identifying Reduced Fat-Free Mass in Health Screening ParticipantsCross-sectional study of 8,736 peopleBiomarkersPaper
Journal of Clinical Densitometry·4 AugSequential therapy following romosozumab: real-world comparison of denosumab and bisphosphonates with 2-year follow-upStudy in peopleInterventionsPaper